Results
AKI, sepsis
SEPSIS
From February 2019 to March 2022, 621 patients with AKI underwent nephrology consultation, and 123 did not have sepsis or they lacked variables of interest for the analysis; thus, 498 were assessed for eligibility, among whom 372 did not meet inclusion criteria, and 34 did not sign the consent form; therefore, 92 patients were randomized, with 48 in the intervention group (probiotics) and 44 in the placebo group (CONSORT Flow diagram.The baseline demographic characteristics of the randomized study participants are described in Study baseline characteristics according to the probiotics or placebo groups.Regarding adherence, 81% in the probiotic group and 77% in the control group consumed at least 80% of the doses (